4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-002051
Director acquired 2,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fust Matthew K · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-01-03 | Grant or award : show line 1 in the form | +2,000 | 19,093 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-01-03 | Grant or award : show line 2 in the form Non-Qualified Stock Option (Right to Buy) | +5,500 | $15.08 | 2024-01-03 | 5,500 | 5,500 | D |
Loading xslF345X03/doc4.xml…